Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulipristal versus surgery for symptomatic uterine fibroids
NL-OMON59719Phase 4Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ulipristal in Fibromyoma (LM) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Uterine Fibroid Symptom Quality of Life symptom severity score and Costs. Started Dec 2024; status: recruiting.
02
Drugs
ulipristal
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on NL-OMON59719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59719.